bisindolylmaleimide IX (RO-31-8220)

News alerts, weekly reports and conference planners

Company:

Roche

Drug class:

PKC inhibitor

Related drugs:

NF1 470G>T	Glioblastoma	NF1 470G>T	Glioblastoma	RO-31-8220 Sensitive: D – Preclinical RO-31-8220 Sensitive : D	RO-31-8220 Sensitive: D – Preclinical RO-31-8220 Sensitive : D
NF1 2195G>T	Glioblastoma	NF1 2195G>T	Glioblastoma	RO-31-8220 Sensitive: D – Preclinical RO-31-8220 Sensitive : D	RO-31-8220 Sensitive: D – Preclinical RO-31-8220 Sensitive : D

Associations
(2)